Inhibikase Therapeutics, Inc.(IKT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IKT Inhibikase Therapeutics, Inc.

未开盘 07-03 13:00:00 EDT

1.15

-0.06

-4.92%

最高1.26	最低1.15	成交量6.81万
今开1.15	昨收1.21	日振幅9.09%
总市值830.22万	流通市值657.92万	总股本721.61万
成交额8.04万	换手率1.19%	流通股本571.85万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"IKT","market":"US","secType":"STK","nameCN":"Inhibikase Therapeutics, Inc.","latestPrice":1.1505,"timestamp":1720026000000,"preClose":1.21,"halted":0,"volume":68062,"delay":0,"floatShares":5718542,"shares":7216145,"eps":-3.326521,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.0595,"latestTime":"07-03 13:00:00 EDT","open":1.15,"high":1.255,"low":1.145,"amount":80400.626476,"amplitude":0.090909,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.326521,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1720166400000},"adr":0,"listingDate":1608699600000,"adjPreClose":1.21,"volumeRatio":3.9110628199263555},"requestUrl":"/m/hq/s/IKT","defaultTab":"news","newsList":[{"id":"2448910958","title":"Inhibikase Therapeutics, Inc.盘中异动 大幅跳水6.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448910958","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448910958?lang=zh_cn&edition=full","pubTime":"2024-07-02 00:16","pubTimestamp":1719850598,"startTime":"0","endTime":"0","summary":"北京时间2024年07月02日00时16分，Inhibikase Therapeutics, Inc.股票出现异动，股价急速下挫6.61%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702001638941f2caa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702001638941f2caa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKT","LENZ","BK4139"],"gpt_icon":0},{"id":"2446886954","title":"Inhibikase Therapeutics, Inc.盘中异动 大幅下跌6.43%报1.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446886954","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446886954?lang=zh_cn&edition=full","pubTime":"2024-06-25 03:40","pubTimestamp":1719258003,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日03时40分，Inhibikase Therapeutics, Inc.股票出现波动，股价大幅下跌6.43%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.63%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625034003af8ef17f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625034003af8ef17f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKT","LENZ","BK4139"],"gpt_icon":0},{"id":"2445240104","title":"Inhibikase Therapeutics, Inc.盘中异动 大幅下挫5.12%报1.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445240104","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445240104?lang=zh_cn&edition=full","pubTime":"2024-06-21 02:10","pubTimestamp":1718907027,"startTime":"0","endTime":"0","summary":"北京时间2024年06月21日02时10分，Inhibikase Therapeutics, Inc.股票出现异动，股价大幅下跌5.12%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.39%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240621021027aef5de4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240621021027aef5de4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKT","BK4139","LENZ"],"gpt_icon":0},{"id":"2444430450","title":"Inhibikase Therapeutics, Inc.盘中异动 股价大跌6.29%报1.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444430450","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444430450?lang=zh_cn&edition=full","pubTime":"2024-06-19 00:08","pubTimestamp":1718726892,"startTime":"0","endTime":"0","summary":"北京时间2024年06月19日00时08分，Inhibikase Therapeutics, Inc.股票出现波动，股价大幅下挫6.29%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240619000812af8e1609&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240619000812af8e1609&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKT","BK4139","LENZ"],"gpt_icon":0},{"id":"2444319558","title":"Inhibikase Therapeutics, Inc.盘中异动 早盘大幅上涨9.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444319558","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444319558?lang=zh_cn&edition=full","pubTime":"2024-06-17 22:45","pubTimestamp":1718635514,"startTime":"0","endTime":"0","summary":"北京时间2024年06月17日22时45分，Inhibikase Therapeutics, Inc.股票出现波动，股价快速拉升9.93%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240617224514941eefd4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240617224514941eefd4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKT","LENZ","BK4139"],"gpt_icon":0},{"id":"2443960403","title":"Inhibikase Therapeutics, Inc.盘中异动 急速下跌9.02%报1.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443960403","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443960403?lang=zh_cn&edition=full","pubTime":"2024-06-15 03:27","pubTimestamp":1718393244,"startTime":"0","endTime":"0","summary":"北京时间2024年06月15日03时27分，Inhibikase Therapeutics, Inc.股票出现波动，股价快速跳水9.02%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240615032725941eeb92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240615032725941eeb92&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","IKT"],"gpt_icon":0},{"id":"2442550088","title":"Inhibikase Therapeutics, Inc.盘中异动 早盘大幅拉升7.23%报1.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442550088","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442550088?lang=zh_cn&edition=full","pubTime":"2024-06-12 22:16","pubTimestamp":1718201784,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日22时16分，Inhibikase Therapeutics, Inc.股票出现波动，股价急速拉升7.23%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.63%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061222162496813bd3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061222162496813bd3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","IKT"],"gpt_icon":0},{"id":"2442873520","title":"Inhibikase Therapeutics, Inc.盘中异动 快速下跌5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442873520","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442873520?lang=zh_cn&edition=full","pubTime":"2024-06-11 03:33","pubTimestamp":1718048033,"startTime":"0","endTime":"0","summary":"北京时间2024年06月11日03时33分，Inhibikase Therapeutics, Inc.股票出现异动，股价急速下跌5.33%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。消息层面，截至03时33分，《Maxim Group维持Inhibikase Therapeutics买入评级，维持目标价8美元》资讯为影响Inhibikase Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611033353aef42e19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611033353aef42e19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","IKT"],"gpt_icon":0},{"id":"2441748235","title":"Inhibikase Therapeutics, Inc.盘中异动 股价大涨5.77%报1.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441748235","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441748235?lang=zh_cn&edition=full","pubTime":"2024-06-06 22:11","pubTimestamp":1717683094,"startTime":"0","endTime":"0","summary":"北京时间2024年06月06日22时11分，Inhibikase Therapeutics, Inc.股票出现异动，股价快速拉升5.77%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606221134941ecfb5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606221134941ecfb5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","IKT"],"gpt_icon":0},{"id":"2438308685","title":"Inhibikase Therapeutics, Inc.盘中异动 早盘大幅下挫8.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2438308685","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438308685?lang=zh_cn&edition=full","pubTime":"2024-05-28 22:14","pubTimestamp":1716905698,"startTime":"0","endTime":"0","summary":"北京时间2024年05月28日22时14分，Inhibikase Therapeutics, Inc.股票出现异动，股价大幅下挫8.84%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.76%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528221459af8ab490&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528221459af8ab490&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKT","BK4139","LENZ"],"gpt_icon":0},{"id":"2437929113","title":"Inhibikase Therapeutics, Inc.盘中异动 股价大跌8.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2437929113","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437929113?lang=zh_cn&edition=full","pubTime":"2024-05-22 22:28","pubTimestamp":1716388117,"startTime":"0","endTime":"0","summary":"北京时间2024年05月22日22时28分，Inhibikase Therapeutics, Inc.股票出现异动，股价快速下挫8.47%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。该信息摘要如下：HC Wainwright & Co.：维持Inhibikase Therapeutics评级，由买入调整至买入评级, 目标价由27.00美元调整至23.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405222228389680f141&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405222228389680f141&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","IKT"],"gpt_icon":0},{"id":"2437221413","title":"HC Wainwright & Co.：维持Inhibikase Therapeutics(IKT.US)评级，由买入调整至买入评级, 目标价由27.00美元调整至23.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2437221413","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437221413?lang=zh_cn&edition=full","pubTime":"2024-05-21 18:55","pubTimestamp":1716288958,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：维持Inhibikase Therapeutics(IKT.US)评级，由买入调整至买入评级, 目标价由27.00美元调整至23.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405211856048782af31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405211856048782af31&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","IKT"],"gpt_icon":0},{"id":"2435379772","title":"Inhibikase Therapeutics, Inc.盘中异动 股价大涨6.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435379772","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435379772?lang=zh_cn&edition=full","pubTime":"2024-05-13 22:43","pubTimestamp":1715611427,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日22时43分，Inhibikase Therapeutics, Inc.股票出现波动，股价大幅上涨6.87%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.20%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513224347792762aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513224347792762aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","IKT"],"gpt_icon":0},{"id":"2434868035","title":"Inhibikase Therapeutics Inc   预计每股亏损79美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2434868035","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434868035?lang=zh_cn&edition=full","pubTime":"2024-05-10 23:14","pubTimestamp":1715354060,"startTime":"0","endTime":"0","summary":"   * Inhibikase Therapeutics Inc    将于5月13日公布截至2024年3月31日的财报() 预计该公司的季度收入将保持不变。*    * LSEG的分析师平均预计Inhibikase Therapeutics Inc每股亏损79美分。* 在过去三个月中，分析师的平均盈利预期下降了约 9.0%。* 华尔街对 Inhibikase Therapeutics Inc 的 12 个月目标价中位数为 17.50 美元，高于其最新收盘价 1.36 美元。5月10日 - 本摘要于北京时间 5 月 10 日 15:14 机器生成。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IKT","LENZ"],"gpt_icon":0},{"id":"2433729275","title":"Inhibikase Therapeutics, Inc.盘中异动 早盘股价大涨10.99%报1.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433729275","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433729275?lang=zh_cn&edition=full","pubTime":"2024-05-08 21:33","pubTimestamp":1715175197,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日21时33分，Inhibikase Therapeutics, Inc.股票出现异动，股价大幅拉升10.99%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.29%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050821331787e09706&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050821331787e09706&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","IKT"],"gpt_icon":0},{"id":"2432905620","title":"Inhibikase Therapeutics, Inc.盘中异动 早盘大幅拉升5.22%报1.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432905620","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432905620?lang=zh_cn&edition=full","pubTime":"2024-05-03 21:56","pubTimestamp":1714744599,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日21时56分，Inhibikase Therapeutics, Inc.股票出现异动，股价大幅上涨5.22%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050321563987e857d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050321563987e857d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","IKT","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.inhibikase.com","stockEarnings":[{"period":"1week","weight":-0.184},{"period":"1month","weight":-0.3815},{"period":"3month","weight":-0.477},{"period":"6month","weight":-0.1414},{"period":"1year","weight":-0.6768},{"period":"ytd","weight":-0.0941}],"compareEarnings":[{"period":"1week","weight":0.0109},{"period":"1month","weight":0.0448},{"period":"3month","weight":0.0748},{"period":"6month","weight":0.1785},{"period":"1year","weight":0.2426},{"period":"ytd","weight":0.1602}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Inhibikase Therapeutics, Inc.于2010年6月3日注册为特拉华州公司。该公司是一家临床阶段制药公司，致力于开发针对帕金森氏病或PD以及大脑内外发生的相关疾病的疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.425952},{"month":2,"riseRate":0.5,"avgChangeRate":-0.118451},{"month":3,"riseRate":0.25,"avgChangeRate":0.045803},{"month":4,"riseRate":0,"avgChangeRate":-0.217435},{"month":5,"riseRate":0.75,"avgChangeRate":0.088455},{"month":6,"riseRate":0,"avgChangeRate":-0.283409},{"month":7,"riseRate":0.25,"avgChangeRate":-0.098977},{"month":8,"riseRate":0.666667,"avgChangeRate":-0.009751},{"month":9,"riseRate":0,"avgChangeRate":-0.186153},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.155622},{"month":11,"riseRate":0.666667,"avgChangeRate":-0.050918},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.028053}],"exchange":"NASDAQ","name":"Inhibikase Therapeutics, Inc.","nameEN":"Inhibikase Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Inhibikase Therapeutics, Inc.(IKT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Inhibikase Therapeutics, Inc.(IKT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Inhibikase Therapeutics, Inc.,IKT,Inhibikase Therapeutics, Inc.股票,Inhibikase Therapeutics, Inc.股票老虎,Inhibikase Therapeutics, Inc.股票老虎国际,Inhibikase Therapeutics, Inc.行情,Inhibikase Therapeutics, Inc.股票行情,Inhibikase Therapeutics, Inc.股价,Inhibikase Therapeutics, Inc.股市,Inhibikase Therapeutics, Inc.股票价格,Inhibikase Therapeutics, Inc.股票交易,Inhibikase Therapeutics, Inc.股票购买,Inhibikase Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Inhibikase Therapeutics, Inc.(IKT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Inhibikase Therapeutics, Inc.(IKT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}